Risks and Opportunities in Synthetic Biology

For all the exciting developments in the synthetic biology industry, there are also concerns.

People can edit genes in their garages these days, so who’s regulating this space?

Plus - we’ll hear about the exciting new business models with biology at their core, including one of the first synbio businesses to trade as a public stock - Ginkgo Bioworks.

Presenter: Gareth Mitchell Producer: Izzy Greenfield

(Image: A petri dish in a lab. Credit: Getty Images)